Do we still need surgery in advanced melanoma?
Prof John Thompson - University of Sydney, Sydney, Australia
20 Nov 2018
ILLUMINATE 301: ipilimumab versus IMO-2125 combined with ipilimumab in anti PD 1...
Prof Paolo Ascierto - Istituto Nazionale Tumori, Milan, Italy
29 Oct 2018
Dosing regiment in the combination of ipilimumab and nivolumab in stage III mela...
Dr Lisette Rozeman - Netherlands Cancer Institute, Amsterdam, Netherlands
29 Oct 2018
COLUMBUS: Encorafenib plus binimetinib versus vemurafenib or encorafenib in pati...
Prof Dirk Schadendorf - Uniklinik Essen, Essen, Germany
29 Oct 2018
Modern melanoma treatment in the UK
Dr Joseph Sacco - University of Liverpool, Liverpool, UK
26 Oct 2018
KEYNOTE022: Triplet therapy for BRAF melanoma
Prof Paolo Ascierto - Istituto Nazionale Tumori - IRCCS "Fondazione G.Pascale", ...
22 Oct 2018
ESMO 2018: Melanoma highlights
Dr Teresa Amaral, Will Davies
22 Oct 2018
Use of T-VEC in early metastatic melanoma
Ms Viola Franke - Netherlands Cancer Institute, Amsterdam, Netherlands
21 Oct 2018
Expansion from CHECKMATE-032; nivolumab and ipilimumab for metastatic urothelial...
Dr Jonathan E. Rosenberg - Memorial Sloan-Kettering Cancer Institute, New York, ...
21 Oct 2018
Editor's Choice for June 2018
Prof Gordon McVie - Founding Editor, ecancer
4 Jul 2018
EHA 2018: The unmet needs in maintenance therapy for multiple myeloma
Prof Meletios Dimopoulos, Dr Shaji Kumar, Prof Meral Beksaç and Prof Wee Joo Ch...
15 Jun 2018
Updates in melanoma from ASCO 2018
Dr Alexander van Akkooi - Netherlands Cancer Institute, Amsterdam, Netherlands
4 Jun 2018
